Skip Navigation
Close Btn

The New Board Question: “What’s Our Exposure to AI‑Driven Misconduct?”

by Robyn Marino
May 24, 2026
Newsletter cover graphic: GC Insider — The New Board Question: What’s Our Exposure to AI-Driven Misconduct? by Daniel Santos, Global Link Law.

By: Daniel Santos, Special Counsel

Two companies. Same AI tools. Same regulatory environment. Completely different risk profiles.

I’ve watched this unfold across healthcare and health tech organizations over the past year. From the outside, everything looks similar: same access to generative AI, same policies, same expectations. But inside the organization, the experience of AI risk feels completely opposite.

When AI Feels Dangerous

In one organization, AI feels dangerous:

When AI Is Controlled and Predictable

In the other, AI is controlled and predictable:

  • Teams know what tools they can use and how.
  • Product development has clear guardrails, often shaped by HIPAA counsel and privacy review before launch.
  • Vendors are vetted for data provenance through structured contract management processes.
  • Issues get surfaced early before they become problems.

The difference isn’t who uses AI. It’s how AI accountability is structured.

The Ownership Gap

When AI risk starts to feel unmanageable, I see the same pattern:

Contrast that with organizations where AI governance actually works. There is clear ownership across the AI lifecycle:

  • Who approves AI tools for employee use and oversees enforcement.
  • Who monitors regulatory changes and updates the policy.
  • Who evaluates vendor models and their training data.
  • Who interprets requirements when the business hits a gray area — often a role for a Fractional Chief Compliance Officer or Fractional General Counsel.
  • Who ensures those decisions translate into product and operations.

Clarity as an Operating Model

This is where clarity becomes essential — not as a formality, but as an operating model. Because AI risk doesn’t break at the point of technology. It breaks in the gap between policy and behavior. And that gap is almost always an ownership problem — the same dynamic we see in healthcare investigations and FCPA matters, where the misconduct is rarely about the technology and almost always about who was supposed to be watching.

The New Board Question

Boards are now asking GCs a new question: “What’s our exposure to AI-driven misconduct?”

If you don’t define your AI posture, someone else will define it for you. For more on how legal teams are reframing these conversations, see Health Tech Founders Don’t Need More Legal Warnings — They Need Better Thinking and Navigating Regulatory Hurdles in the Health Tech Industry, or browse all Global Link Law Insights.

A Question for Your Team

How is AI accountability actually structured in your organization today?

If you want to talk through your AI governance or regulatory exposure with Daniel, the Global Link Law team offers a 30-minute discovery call — contact us to schedule. You can also explore our full Practice Areas or learn why companies choose Global Link Law.

This newsletter is for informational purposes only and does not constitute legal advice. Reading this post does not create an attorney-client relationship with the author or their firm. If you have questions about how these issues may affect your organization, you should consult qualified legal counsel.

The information provided on this website is for general informational purposes only and should not be considered legal advice. No attorney-client relationship is created by accessing or using this website. Please consult with a qualified attorney before making any legal decisions. Global Link Law is not liable for any reliance on the information provided. Prior results do not guarantee a similar outcome.

Strategic Legal Counsel for Healthcare & Health Technology

Your organization faces legal and regulatory complexity that demands more than outside counsel — it demands a partner who has sat on your side of the table.

From government investigations and FCPA matters to healthcare M&A and payer contracting, we’ve handled it from the inside and from the courtroom.

Whether you need fractional leadership, transactional support, or a defensible compliance framework, we deliver counsel built around what the business actually needs. What sets us apart is real-world in-house experience — our partners have served in senior legal roles within large and publicly traded companies, giving them a direct understanding of what business leaders and boards actually need from legal counsel.

Book a discovery call now